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IpaD, the putative needle-tip protein of the Shigella ﬂexneri type III secretion
system, has been overexpressed and puriﬁed. Crystals were grown of the native
protein in space group P212121, with unit-cell parameters a = 55.9, b = 100.7,
c = 112.0 A ˚ , and data were collected to 2.9 A ˚ resolution. Analysis of the native
Pattersonmaprevealedapeakat50%oftheoriginontheHarkersectionv=0.5,
suggesting twofold non-crystallographic symmetry parallel to the b crystallo-
graphic axis. As attempts to derivatize or grow selenomethionine-labelled
protein crystals failed, in-drop proteolysis was used to produce new crystal
forms. A trace amount of subtilisin Carlsberg was added to IpaD before sparse-
matrix screening, resulting in the production of several new crystal forms. This
approach produced SeMet-labelled crystals and diffraction data were collected
to 3.2 A ˚ resolution. The SeMet crystals belong to space group C2, with unit-cell
parameters a = 139.4, b = 45.0, c = 99.5 A ˚ ,   = 107.9 . An anomalous difference
Patterson map revealed peaks on the Harker section v = 0, while the self-
rotation function indicates the presence of a twofold noncrystallographic
symmetry axis, which is consistent with two molecules per asymmetric unit.
1. Introduction
Shigella ﬂexneri, the causative agent of shigellosis, is a Gram-negative
bacterial pathogen that initiates infection by invading cells of the
colonic epithelium in a process which is dependent on a type III
secretion system (T3SS; Phalipon & Sansonetti, 2003). The T3SS is
composed of a basal body, which traverses both bacterial membranes,
and an external needle through which effector proteins are secreted
(Blocker et al., 2001). During S. ﬂexneri infection, secretion is acti-
vated by contact of the tip of the needle complex with host cells,
resulting in formation of a pore in the host-cell membrane that is
contiguous with the needle. Other effector proteins are injected via
this apparatus directly into the host-cell cytoplasm (for a review, see
Johnson et al., 2005).
Of the T3SS effectors, IpaB, IpaC and IpaD are essential for
invasion (Menard et al., 1993). IpaB and IpaC have been demon-
strated to insert into the host-cell membrane and are therefore
suggested to form the translocation pore (Blocker et al., 1999). Cells
lacking IpaD are not only incapable of pore insertion and invasion,
but also demonstrate impaired effector secretion control (Picking et
al., 2005). IpaD was originally proposed to form a plug in the T3SS
with IpaB (Menard et al., 1994), but more recent data has demon-
strated that its role is more complex (Picking et al., 2005). Deletions
within the N-terminal third of the molecule do not affect invasion of
the bacteria into host cells, although the insertion of IpaB/IpaC into
membranes is slightly impaired. However, even short deletions (ﬁve
residues) in the C-terminus of IpaD completely abolish the invasive
phenotype and pore insertion. These observations, combined with the
functional homology between IpaD and LcrV, a protein recently
shown to be assembled at the tip of the Yersinia pestis T3SS needle
(Mueller et al., 2005), suggest that IpaD may play a role in regulating
insertion of the IpaB/IpaC translocon pore from the tip of the
S. ﬂexneri needle.
Our laboratory has recently determined the crystal structure of
MxiH, the needle subunit, and assembled a molecular model of the
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All rights reservedT3SS needle by docking it into a 16 A ˚ EM reconstruction of the
S. ﬂexneri needle (Cordes et al., 2003; Deane, Cordes et al., 2006;
Deane, Roversi et al., 2006). As part of an ongoing study into the
interactions of the T3SS with host cells, we have now expressed,
puriﬁed and crystallized IpaD. The three-dimensional structure of
IpaD, in conjunction with the structure of the MxiH needle and other
tip proteins such as LcrV (Derewenda et al., 2004), will hopefully
allow us to delineate the mechanism of translocon insertion.
2. Experimental procedures
2.1. Expression and purification
The DNA fragment of the ipaD gene encoding residues 15–332 was
produced using the methods described previously (Harrington et al.,
2003; Picking et al., 2005) and subcloned into the pET-15b vector.This
construct placed the gene in frame with an N-terminal hexahistidine
tag. IpaDN14 was expressed in Escherichia coli BL21 (DE3) cells
grown in LB media containing 100 mgm l
 1 ampicillin. Cells were
grown at 310 K to an A600nm of 0.6 and protein overexpression was
induced by the addition of 1.0 mM IPTG. After 3 h, cells were
harvested by centrifugation (4000g, 15 min, 277 K) and pellets were
frozen at 193 K. Cell pellets were resuspended in lysis buffer [20 mM
Tris–HCl pH 7.5, 500 mM NaCl and Complete EDTA-free protease
inhibitor cocktail (Roche)] and lysed using an Emulsiﬂex-C5
Homogeniser (Glen Creston, UK). The resultant cell suspension was
centrifuged (20 000g, 30 min, 277 K) and the soluble fraction was
applied onto a pre-charged 5 ml His-Trap HP nickel-afﬁnity column
(Amersham Biosciences). Protein was eluted using a gradient of
0–1 M imidazole in lysis buffer. Fractions containing IpaDN14 were
further puriﬁed by gel-ﬁltration chromatography using a HiLoad
26/60 Superdex 75 column (Amersham Biosciences) equilibrated in
20 mM Tris–HCl pH 7.5, 100 mM NaCl, 10 mM DTT. IpaDN14
eluted as a single monomeric peak and was demonstrated to be pure
by SDS–PAGE; mass-spectrometric analysis (data not shown)
conﬁrmed the molecular weight of the protein minus the N-terminal
methionine (37 374 Da). Fractions containing puriﬁed IpaDN14 were
pooled, concentrated using 5 kDa molecular-weight VivaSpin
centrifugal concentrators (VivaScience, Sartorius Group) to
approximately 70 mg ml
 1 and stored at 193 K in 50 ml aliquots.
SeMet-labelled IpaDN14 was produced by expression in the E.coli
met
  auxotrophic strain B834 (DE3). Cultures were grown in LB
media to an A600nm of 0.2, pelleted (4000g, 15 min, 277 K) and washed
in phosphate-buffered saline three times. Washed cells were used to
inoculate SelenoMet Medium Base containing SelenoMet Nutrient
Mix, l-selenomethionine (40 mgm l
 1; Molecular Dimensions Ltd,
UK) and ampicillin (100 mgm l
 1). Cultures were grown at 310 Kuntil
an A600nm of 0.6 was reached, whereupon the solutions were cooled to
293 K and protein overexpression was induced by the addition of
1.0 mM IPTG. After 16 h, cells were harvested and SeMet-labelled
protein was puriﬁed as described above. Mass-spectrometric analysis
conﬁrmed full incorporation of SeMet, including the N-terminal
methionine (data not shown), in contrast to the native protein. We
assume this is a consequence of the incorporation of the selenium
making the N-terminal peptide bond less likely to be cleaved.
2.2. Crystallization and limited proteolysis
Initial crystallization conditions were obtained by sparse-matrix
screening (Jancarik & Kim, 1991) using the sitting-drop vapour-
diffusion technique. Drops were prepared by mixing 0.2 ml protein
solution (70 mg ml
 1,2 0m M Tris–HCl pH 7.5, 100 mM NaCl, 10 mM
DTT) with 0.2 ml reservoir solution using a Tecan crystallization
robot (Tecan UK, Theale, UK) and were equilibrated against 100 ml
reservoir solution at 293 K. Initial crystals of IpaDN14 (crystal form
1) grew in 3 d in condition No. 33 of Molecular Dimensions Screen 1
[30%(w/v) PEG 4000, 0.1 M Tris–HCl pH 8.5, 0.2 M MgCl2]. Subse-
quent screening using handmade conditions yielded diffraction-
quality crystals in PEG 4000 concentrations ranging from 25 to
28%(w/v). Mercury derivatives were prepared by adding 1 mlo f
10 mM HgCl2 in reservoir solution to the 0.4 ml drop. Crystals were
soaked for 3 h at 293 K.
One IpaDN14 crystal form (crystal form 2) grew over a period of
12 months in 10%(v/v) PEG 400, 0.1 M NaCl, 0.1 M Tris–HCl pH 7.0
(Fig. 1a) and was discovered to be an N-terminal truncation of
IpaDN14. In an attempt to reproduce this and ﬁnd new crystal forms,
in-drop limited proteolysis was carried out (as in Gaur et al., 2004).
The broad-spectrum serine protease subtilisin Carlsberg from
Bacillus licheniformis (Sigma–Aldrich) was added to IpaDN14 in a
1:5000 enzyme:protein ratio by weight before sparse-matrix screening
was carried out as described above. Diffraction-quality native crystals
were obtained in Molecular Dimensions Screen 1 condition No. 24
[30%(v/v) PEG 400, 0.1 M Na HEPES pH 7.5, 0.2 M MgCl2] (crystal
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Figure 1
(a) Monoclinic crystals of IpaD crystal form 2 produced by in-drop proteolysis. (b)
SDS–PAGE of protein derived from crystals with (CF-3 and CF-5) and without
(CF-1) subtilisin treatment (see text for full description). The subscript denotes the
portion of IpaD present in each band as determined by sequencing (FL, full length;
120, N-terminal deletion to residue 120). Molecular-weight markers are shown in
lane 2; the marker identiﬁed with ‘M’ corresponds to a MW of 42 kDa.form 3) and Molecular Dimensions Screen 2 condition No. 19
[10%(w/v) PEG 8000, 0.1 M Na HEPES pH 7.5, 8%(v/v) ethylene
glycol] (crystal form 4A; Fig. 1b). Diffraction-quality SeMet crystals
were obtained in Molecular Dimensions Screen 1 condition No. 23
[28%(v/v) PEG 400, 0.1 M Na HEPES pH 7.5, 0.2 M CaCl2] (crystal
form 5) and Molecular Dimensions Screen 1 condition No. 34
[30%(v/v) PEG 400, 0.1 M Tris–HCl pH 8.5, 0.2 M sodium citrate]
(crystal form 4B). Numerous other conditions in Molecular Dimen-
sions Screens 1 and 2 yielded crystals that were too small to collect
data from.
2.3. Data collection and processing
Crystal forms 1, 2, 3, 4A and 5 were cryoprotected in reservoir
solution containing 20%(v/v) glycerol, 20%(v/v) PEG 400, 5%(v/v)
PEG 400, 25%(v/v) ethylene glycol and 5%(v/v) PEG 400, respec-
tively, and ﬂash-cryocooled in liquid nitrogen prior to data collection.
Crystal form 4B was mounted and ﬂash-cryocooled directly in the
cryostream.
Diffraction data were recorded at 100 K (Table 1). Data were
indexed and integrated in MOSFLM (Leslie, 1992) and scaled with
SCALA (Evans, 1997) within the CCP4 program suite (Collaborative
Computational Project, Number 4, 1994). A ﬂuorescence scan on a
SeMet crystal (CF-4B) across the Se edge yielded values of f0 =  8.0
and f00 = 5.2 using the program CHOOCH (Evans & Pettifer, 2001).
3. Results and discussion
Intact IpaDN14 yielded plate-shaped crystals (CF-1) belonging to
space group P212121 (Table 1). Calculation of a native Patterson map
revealed a peak at  50% of the origin on Harker section v = 0.5,
consistent with two molecules per asymmetric unit related by a pure
translation (Fig. 2). The value of the Matthews coefﬁcient is
2.1 A ˚ 3 Da
 1 for two molecules, corresponding to a solvent content of
42% (Matthews, 1968). Attempts to grow diffraction-quality SeMet
crystals in this crystal form were unsuccessful. Soaking the crystals
with mercury increased the quality of diffraction of the crystals but
did not yield a reliable set of Hg sites, despite using the available
Patterson-solving software.
During optimization of CF-1 a second crystal form was observed
(CF-2) which took 12 months to grow and belongs to space group C2
(Fig. 1). One crystal was used for data collection and the remainder
were re-solubilized, run on SDS–PAGE and N-terminal sequenced.
This revealed a major band corresponding to an N-terminal trunca-
tion beginning at residue 144 (data not shown). The value of the
Matthews coefﬁcient is 2.4 A ˚ 3 Da
 1 for two molecules, corresponding
to 49% solvent content.
The contents of CF-2 revealed that the N-terminal third of IpaD is
susceptible to degradation and suggested that limited proteolysis
could trim these regions. In an attempt to reproduce CF-2 and search
for new crystal forms, the broad-spectrum protease subtilisin
Carlsberg was added in trace amounts to IpaDN14 before screening.
Plate-shaped crystals were grown in three new crystal forms (CF-3,
CF-4 and CF-5; Table 1) and analysis by SDS–PAGE revealed various
degrees ofN-terminal truncation (Fig. 1b). The value of the Matthews
coefﬁcient is 2.1 and 2.5 A ˚ 3 Da
 1 for CF-3 and CF-4, respectively, for
two molecules per asymmetric unit and is 2.6 A ˚ 3 Da
 1 in CF-5 for
four molecules.
Anomalous difference Patterson maps for SeMet derivatives of
CF-4 were calculated within autoSHARP (Vonrhein et al., 2005) using
(E
2   1) coefﬁcients and strict outlier rejection. The positions of ten
Se atoms were obtained using the Patterson-solving software within
crystallization communications
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Table 1
IpaD X-ray diffraction data-collection statistics.
Values in parentheses are for the highest resolution shells.
CF-1 CF-2 CF-3 CF-4A CF-4B SeMet MAD CF-5
Native Mercury soak Native Native Native Peak 1 Peak 2 Peak 3 Remote Native
X-ray source ESRF, ID14-3 ESRF, ID23-1 ESRF, ID14-1 ESRF, ID23-2 ESRF, ID23-1 ESRF, ID23-1 ESRF, BM16
Detector MAR CCD MAR CCD ADSC scanner MAR CCD ADSC scanner ADSC scanner MAR CCD
Space group P212121 P212121 C2 C2 C2 C2 P21
Unit-cell parameters
a (A ˚ ) 55.9 56.2 77.9 204.6 139.4 136.9 44.9
b (A ˚ ) 100.7 102.4 91.5 45.1 45.0 44.3 205.9
c (A ˚ ) 112.0 111.5 54.9 56.8 99.5 100.0 110.9
  ( ) 96.4 105.2 107.9 107.4 102.5
Wavelength (A ˚ ) 0.931 1.0055 0.934 0.873 0.9757 0.9792 0.9792 0.9792 0.9757 0.9790
Resolution limits
(A ˚ )
75–2.7
(2.8–2.7)
38–3.2
(3.4–3.2)
42–2.0
(2.1–2.0)
30–3.5
(3.7–3.5)
43–2.8
(3.0–2.8)
34–3.4
(3.6–3.4)
34–3.4
(3.6–3.4)
34–3.2
(3.4–3.2)
48–3.3
(3.5–3.3)
41–3.9
(4.1–3.9)
Completeness (%) 90.1 (68.2) 99.9 (100.0) 99.2 (99.8) 96.5 (96.5) 99.0 (96.3) 99.2 (96.4) 99.4 (96.7) 99.5 (100.0) 97.8 (87.5) 86.4 (86.7)
Unique reﬂections 14594 11143 24238 5840 14425 7938 8009 9703 8518 7495
Multiplicity 7.0 (3.0) 7.8 (7.9) 3.0 (3.0) 4.6 (4.7) 5.2 (4.6) 6.9 (6.6) 7.0 (6.8) 3.6 (3.7) 6.8 (6.2) 8.8 (8.2)
Rmerge† 14.1 (48.2) 14.0 (37.2) 5.3 (41.8) 13.2 (41.6) 11.5 (29.2) 9.6 (33.6) 8.4 (23.1) 11.0 (33.5) 8.9 (25.8) 22.7 (42.1)
I/ (I) 3.9 (1.6) 3.8 (1.8) 7.9 (1.7) 3.0 (1.5) 3.1 (1.9) 5.6 (2.2) 5.6 (3.0) 4.5 (2.0) 5.9 (2.7) 2.6 (1.7)
Ranom‡ — — — — — 6.7 (15.0) 5.5 (9.0) 5.4 (11.4) 4.0 (10.8) —
† Rmerge = 100  
P
h½
P
i jhIðhÞi   IðhÞij=
P
i IðhÞi , where I(h)i is the ith observation of reﬂection h and hI(h)i is the mean intensity of all observations of h.‡ Ranom = 100   P
h jhIþi h I ij=
P
hðhIþiþh I iÞ, where hI
+i and hI
 i are the mean intensities of the Bijvoet pairs for observation h.
Figure 2
Harker section v = 0.5 of the native Patterson map of IpaD crystal form 1calculated
using PATTERSON (Collaborative Computational Project, Number 4, 1994) at
3.5 A ˚ . The map is drawn with a minimum contour level of 1.5  with 0.5 
increments.autoSHARP and were reﬁned using SHARP. The ten sites clustered
into two sets of ﬁve related by the twofold peak in the self-rotation
function (Fig. 3). Structure determination and reﬁnement in the
various crystal forms is under way.
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Figure 3
The   = 180  section of the self-rotation function calculated for the crystal form 4
SeMet peak 1 data set using MOLREP (Collaborative Computational Project,
Number 4, 1994) with an integration radius of 20.0 A ˚ and data in the resolution
range 15–4 A ˚ . The peak (marked with an X) at (!, ’) = (22, 0 ) represents 91% of
the peak for the crystallographic twofold axis.